Isam Alobid

Grupo de investigación

Inmunoalergia respiratoria clínica y experimental (IRCE) Accredited researcher (R3A)

ialobid@clinic.cat 0000-0001-7204-5599

Síguelo/a en:

El perfil Researchgate de Isam . Este enlace se abre en una nueva pestaña.

Publicaciones destacadas

Paediatric Barcelona Olfactory Test-6 (pBOT-6): Validation of a Combined Odour Identification and Threshold Screening Test in Healthy Spanish Children and Adolescents

Autores:
Mariño-Sánchez F; Valls-Mateus M; Fragola C; de Los Santos G; Aguirre A;

(...)

Santamaría A; Rojas Lechuga MJ; Cobeta I; Alobid I; Mullol J .

Referencia: Journal Of Investigational Allergology And Clinical Immunology 2020.
Olfactory Training Prevents Olfactory Dysfunction Induced by Bulbar Excitotoxic Lesions: Role of Neurogenesis and Dopaminergic Interneurons

Autores:
Marin, Concepcio; Laxe, Sara; Langdon, Cristobal; Alobid, Isam; Berenguer, Joan;

Fuentes, Mireya; Bernabeu, Montserrat; Mullol, Joaquim.

Referencia: Molecular Neurobiology 2019.
Recovery of Olfactory Function After Excitotoxic Lesion of the Olfactory Bulbs Is Associated with Increases in Bulbar SIRT1 and SIRT4 Expressions

Autores:
Marin C; Langdon C; Alobid I; Fuentes M; Bonastre M;

Mullol J.

Referencia: Molecular Neurobiology 2019.
European position paper on diagnostic tools in rhinology

Autores:
Rimmer J; Hellings P; Lund VJ; Alobid I; Beale T;

(...)

Psaltis A; Surda P; Tomazic PV; Vent J; Fokkens W.

Referencia: Rhinology 2019.
Patient Advisory Board for Chronic Rhinosinusitis - A EUFOREA initiative

Autores:
Pugin B; Deneyer L; Bachert C; Alobid I; Bousquet J;

(...)

Pereira-Perez C; Tomazic PV; Vanderveken O; Hellings PW; Seys SF .

Referencia: Rhinology 2019.
The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life

Autores:
Khan A; Huynh TMT; Vandeplas G; Joish VN; Mannent LP;

(...)

Hox V; Toskala E; Scadding G; Lund V; Bachert C .

Referencia: Rhinology 2019.
Self-perception of olfactory dysfunction is associated with history of Traumatic Brain Injury: post-hoc analysis from the OLFACAT survey

Autores:
Langdon C; Alobid I; Quinto L; Valero A; Picado C;

Marin C; Mullol J .

Referencia: Rhinology 2019.
Modified nasal floor and inferior meatus flap for septal perforation repair. Extension and limits.

Autores:
Santamaria-Gadea A; et al; Alobid I;

Referencia: Rhinology. 2018.
Olfactory Dysfunction in Neurodegenerative Diseases

Autores:
Marin C; Vilas D; Langdon C; Alobid I; López-Chacón M;

Haehner A; Hummel T; Mullol J.

Referencia: Current Allergy And Asthma Reports 2018.

Proyectos destacados

Expression of Rupatadine on PAF-induced inflammation in blood eosinophils and epithelial cells from nasal polyps and healthy nasal mucosa (RINOPAF-2 Study).

Investigador/a principal: Joaquim Mullol I Miret

Financiador: URIACH S.A

Código: RINOPAF-02-2018

Duración: 01/01/2019 - 31/12/2021
El impacto de la inflamación sobre el sentido del olfato en pacientes con poliposis nasal: El rol de los eosinófilos sobre la neurogenesis del neuroepitelio olfatorio.

Investigador/a principal: Isam Alobid

Financiador: Fundació Privada Clínic per a la Recerca Biomèdica (Sede o evento); Fondo Investigaciones Sanitarias (FIS)

Código: (PI15/00262)

Duración: 01/01/2016 - 31/12/2019
Study of the antiinflammatory mechanisms of action of MP29-02, compared to fluticasone propionate and azelastine alone, in healthy and inflamed human ansal mucosa: regulation on anti- and pro-inflammatory genes and GR.

Investigador/a principal: Joaquim Mullol I Miret

Financiador: MEDA Pharma

Código: DYMECOS II

Duración: 01/01/2016 - 31/12/2019
Randomized double-blind, phase III, placebo controlled, to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.

Financiador: Sanofi Aventis, S.A. ; CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Participante)

Duración: 01/01/2016
Randomized double-blind, phase II, placebo controlled, 2 arm study to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.

Financiador: Sanofi Aventis, S.A. ; CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Participante)

Duración: 01/01/2014

Isam Alobid

Grupo de investigación

Publicaciones destacadas

Proyectos destacados

Expression of Rupatadine on PAF-induced inflammation in blood eosinophils and epithelial cells from nasal polyps and healthy nasal mucosa (RINOPAF-2 Study).

El impacto de la inflamación sobre el sentido del olfato en pacientes con poliposis nasal: El rol de los eosinófilos sobre la neurogenesis del neuroepitelio olfatorio.

Study of the antiinflammatory mechanisms of action of MP29-02, compared to fluticasone propionate and azelastine alone, in healthy and inflamed human ansal mucosa: regulation on anti- and pro-inflammatory genes and GR.

Randomized double-blind, phase III, placebo controlled, to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.

Randomized double-blind, phase II, placebo controlled, 2 arm study to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.

Suscríbete a la Newsletter del Clínic